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We live in a scientific universe in which 
subject boundaries are increasingly 
porous. Department definitions in 
many institutions are either close to 
meaningless or nonexistent, and many 
faculty count themselves as active par-
ticipants in at least two, if not more, 
of the major disciplines of biology. 
Thus, it is with great pleasure that we 
announce a new cross-listing project 
for the 
 
JEM
 
 and the 
 
JCB
 
.
An increasing number of papers in 
the two journals include subject matter 
vital to both immunologists and cell 
biologists. For these papers, we will 
include a listing not only on the table 
of contents of the hosting journal, but 
also on the online table of contents of 
the sister journal (both the 
 
JEM
 
 and 
 
JCB
 
 are published by the Rockefeller 
University Press). 
 
JCB
 
 subscribers will 
get free access to the listed 
 
JEM
 
 articles, 
and vice versa. The relevant papers 
will be identified by the editors, often 
on the recommendations of our re-
viewers or submitting authors. This 
arrangement addresses the need to 
bring together the fields of cell biology, 
immunology, human disease, and 
microbial pathogenesis.
Based on our subscription lists, the 
 
JEM
 
 and 
 
JCB
 
 readerships do not over-
lap much. Thus, the cross-listing will 
give extra exposure to papers at the 
interface between these subject areas, 
and make these papers accessible to 
readers who might otherwise not have 
seen a given paper, were it to have 
appeared in only one journal. Basic 
mechanisms of cellular motility and 
organization will be brought to the 
attention of those studying immune 
activation, immune cell interactions 
will be highlighted for those studying 
signaling, and a wide array of patho-
gens and human disease states will be 
featured as potential models for cell 
biology investigation.
The 
 
JEM
 
 and 
 
JCB
 
 are both leading 
journals in their fields, and immunology 
and cell biology represent two of the 
biggest fields in terms of the number 
of papers and journals published. 
Readers are struggling just to keep up 
with what is published in the top tier 
journals in their own field. We hope 
to do some of the work for these readers 
by alerting them to relevant content 
in another leading journal—a journal 
that they might not have time to scan 
in its entirety.
By cross-listing relevant content, 
we feel we will enhance the cause of 
communication between scientific 
communities that do not interact nearly 
as much as they should. Further, by 
increasing the visibility of papers at 
the interface of experimental medicine 
and cell biology, both the 
 
JCB
 
 and the 
 
JEM
 
—not-for-profit journals edited 
by your colleagues and whose contents 
are available free online 6 months after 
publication—will become even more 
attractive choices for submitting your 
best work. Let the collaborations begin!